Skip to main content
. 2020 Sep 22;13:3243–3254. doi: 10.2147/IDR.S269797

Figure 1.

Figure 1

Multiple sclerosis drugs as potential therapeutic agents for COVID-19. Drugs such as glatiramer acetate, vitamin D3, dimethyl fumarate, monomethyl fumarate, interferon-β, natalizumab or ocrelizumab, boost NK cell activity that could potentially eradicate SARS-CoV-2 virally infected cells.